Close

Baird Downgrades Tandem Diabetes Care (TNDM) to Neutral

Go back to Baird Downgrades Tandem Diabetes Care (TNDM) to Neutral

Feltl & Co Downgrades Tandem Diabetes Care (TNDM) to Buy

November 2, 2016 10:52 AM EDT

Feltl & Co downgraded Tandem Diabetes Care (NASDAQ: TNDM) from Strong Buy to Buy.

For an analyst ratings summary and ratings history on Tandem Diabetes Care click here. For more ratings news on Tandem Diabetes Care click here.

Shares of Tandem Diabetes Care closed at $5.35 yesterday.

... More

UPDATE: Stifel Downgrades Tandem Diabetes Care (TNDM) to Hold

November 2, 2016 7:22 AM EDT

(Updated - November 2, 2016 10:59 AM EDT)

Stifel downgraded Tandem Diabetes Care (NASDAQ: TNDM) from Buy to Hold with a price target of $3.50 (from $15.00).

Analyst Rick Wise commented on the rating change, saying, "We are downgrading TNDM shares to Hold from Buy following a... More